Absci Corp Stock, NASDAQ:ABSI
18105 SE Mill Plain Boulevard, Suite 350, Vancouver, Washington 98683
United States of America
Number of Employees: 212
Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.